Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2014 (2014), Article ID 901276, 9 pages
http://dx.doi.org/10.1155/2014/901276
Research Article

Elevated Dengue Virus Nonstructural Protein 1 Serum Levels and Altered Toll-Like Receptor 4 Expression, Nitric Oxide, and Tumor Necrosis Factor Alpha Production in Dengue Hemorrhagic Fever Patients

1Institute of Health Sciences, Laboratory of Cellular Activation, Federal University of Triângulo Mineiro, 38025-350 Uberaba, MG, Brazil
2Institute of Health Sciences, Department of Infectious and Parasitic Diseases, Federal University of Triângulo Mineiro, 38025-350 Uberaba, MG, Brazil
3Human Immunology Research Group, Technical Health School, Federal University of Paraiba (UFPB), 58051-900 João Pessoa, PB, Brazil

Received 18 August 2014; Revised 18 November 2014; Accepted 25 November 2014; Published 11 December 2014

Academic Editor: Jean-Paul Gonzalez

Copyright © 2014 Denise Maciel Carvalho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. Guzman, S. B. Halstead, H. Artsob et al., “Dengue: a continuing global threat,” Nature Reviews Microbiology, vol. 8, no. 12, pp. S7–S16, 2010. View at Publisher · View at Google Scholar
  2. O. J. Brady, P. W. Gething, S. Bhatt et al., “Refining the global spatial limits of dengue virus transmission by evidence-based consensus,” PLoS Neglected Tropical Diseases, vol. 6, no. 8, Article ID e1760, 2012. View at Publisher · View at Google Scholar
  3. N. E. A. Murray, M. B. Quam, and A. Wilder-Smith, “Epidemiology of dengue: past, present and future prospects,” Clinical Epidemiology, vol. 5, no. 1, pp. 299–309, 2013. View at Google Scholar
  4. J. G. Rigau-Pérez, G. G. Clark, D. J. Gubler, P. Reiter, E. J. Sanders, and A. V. Vorndam, “Dengue and dengue haemorrhagic fever,” The Lancet, vol. 352, no. 9132, pp. 971–977, 1998. View at Google Scholar
  5. I. Kurane and F. E. Ennis, “Immunity and immunopathology in dengue virus infections,” Seminars in Immunology, vol. 4, no. 2, pp. 121–127, 1992. View at Google Scholar · View at Scopus
  6. M. G. Guzman and S. Vazquez, “The complexity of antibody-dependent enhancement of dengue virus infection,” Viruses, vol. 2, no. 12, pp. 2649–2662, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Kurane, B. L. Innis, A. Nisalak et al., “Human T cell response to dengue virus antigens. Proliferative responses and interferon gamma production,” The Journal of Clinical Investigation, vol. 83, no. 2, pp. 506–513, 1989. View at Google Scholar
  8. A. L. Rothman, “Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms,” Nature Reviews Immunology, vol. 11, no. 8, pp. 532–543, 2011. View at Google Scholar
  9. A. L. Rothman and F. A. Ennis, “Immunopathogenesis of dengue hemorrhagic fever,” Virology, vol. 257, no. 1, pp. 1–6, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. U. C. Chaturvedi, R. Agarwal, E. A. Elbishbishi, and A. S. Mustafa, “Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis,” FEMS Immunology and Medical Microbiology, vol. 28, no. 3, pp. 183–188, 2000. View at Google Scholar
  11. S. Yacoub, J. Mongkolsapaya, and G. Screaton, “The pathogenesis of dengue,” Current Opinion in Infectious Diseases, vol. 26, no. 3, pp. 284–289, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. R. M. Scott, A. Nisalak, U. Cheamudon, S. Seridhoranakul, and S. Nimmannitya, “Isolation of dengue viruses from peripheral blood leukocytes of patients with hemorrhagic fever,” Journal of Infectious Diseases, vol. 141, no. 1, pp. 1–6, 1980. View at Publisher · View at Google Scholar · View at Scopus
  13. W. C. Hall, T. P. Crowell, D. M. Watts et al., “Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis,” The American Journal of Tropical Medicine and Hygiene, vol. 45, no. 4, pp. 408–417, 1991. View at Google Scholar
  14. K. Jessie, M. Y. Fong, S. Devi, S. K. Lam, and K. T. Wong, “Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization,” Journal of Infectious Diseases, vol. 189, no. 8, pp. 1411–1418, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. E. L. A. Braga, P. Moura, L. M. O. Pinto et al., “Detection of circulant tumor necrosis factor–α, soluble tumor necrosis factor p75 and interferon-γ in Brazilian patients with dengue fever and dengue hemorrhagic fever,” Memorias do Instituto Oswaldo Cruz, vol. 96, no. 2, pp. 229–232, 2001. View at Google Scholar
  16. M. T. Fernández-Mestre, K. Gendzekhadze, P. Rivas-Vetencourt, and Z. Layrisse, “TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients,” Tissue Antigens, vol. 64, no. 4, pp. 469–472, 2004. View at Google Scholar
  17. A. Chuansumrit, N. Anantasit, W. Sasanakul et al., “Tumour necrosis factor gene polymorphism in dengue infection: association with risk of bleeding,” Paediatrics and International Child Health, vol. 33, no. 2, pp. 97–101, 2013. View at Google Scholar
  18. Y.-T. Yen, H.-C. Chen, Y.-D. Lin, C.-C. Shieh, and B. A. Wu-Hsieh, “Enhancement by tumor necrosis factor alpha of dengue virus-induced endothelial cell production of reactive nitrogen and oxygen species is key to hemorrhage development,” Journal of Virology, vol. 82, no. 24, pp. 12312–12324, 2008. View at Google Scholar
  19. P. Marianneau, A.-M. Steffan, C. Royer et al., “Infection of primary cultures of human Kupffer cells by dengue virus: no viral progeny synthesis, but cytokine production is evident,” Journal of Virology, vol. 73, no. 6, pp. 5201–5206, 1999. View at Google Scholar
  20. N. Valero, L. M. Espina, G. Añez, E. Torres, and J. A. Mosquera, “Short report: Increased level of serum nitric oxide in patients with dengue,” The American Journal of Tropical Medicine and Hygiene, vol. 66, no. 6, pp. 762–764, 2002. View at Google Scholar
  21. P. C. F. Neves-Souza, E. L. Azeredo, S. M. O. Zagne et al., “Inducible nitric oxide synthase (iNOS) expression in monocytes during acute Dengue Fever in patients and during in vitro infection,” BMC Infectious Diseases, vol. 5, article 64, 2005. View at Publisher · View at Google Scholar
  22. T. R. Kreil and M. M. Eibl, “Nitric oxide and viral infection: No antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo,” Virology, vol. 219, no. 1, pp. 304–306, 1996. View at Google Scholar
  23. P. Nicotera, B. Brune, and G. Bagetta, “Nitric oxide: inducer or suppressor of apoptosis?” Trends in Pharmacological Sciences, vol. 18, no. 6, pp. 189–190, 1997. View at Google Scholar
  24. G. Karupiah, Q. W. Xie, R. M. L. Buller, C. Nathan, C. Duarte, and J. D. MacMicking, “Inhibition of viral replication by interferon-γ-induced nitric oxide synthase,” Science, vol. 261, no. 5127, pp. 1445–1448, 1993. View at Google Scholar
  25. M. Saura, C. Zaragoza, A. McMillan et al., “An antiviral mechanism of nitric oxide: inhibition of a viral protease,” Immunity, vol. 10, no. 1, pp. 21–28, 1999. View at Google Scholar
  26. L. G. Guidotti and F. V. Chisari, “Noncytolytic control of viral infections by the innate and adaptive immune response,” Annual Review of Immunology, vol. 19, pp. 65–91, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. A. G. Bowie and I. R. Haga, “The role of Toll-like receptors in the host response to viruses,” Molecular Immunology, vol. 42, no. 8, pp. 859–867, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. S.-Y. Zhang, E. Jouanguy, V. Sancho-Shimizu et al., “Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses,” Immunological Reviews, vol. 220, no. 1, pp. 225–236, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. M. D. de Kruif, T. E. Setiati, A. T. A. Mairuhu et al., “Differential gene expression changes in children with severe dengue virus infections,” PLoS Neglected Tropical Diseases, vol. 2, no. 4, article e215, 2008. View at Google Scholar
  30. O. Takeuchi and S. Akira, “Innate immunity to virus infection,” Immunological Reviews, vol. 227, no. 1, pp. 75–86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Essakalli, O. Atouf, N. Bennani, N. Benseffaj, S. Ouadghiri, and C. Brick, “Toll-like receptors,” Pathologie Biologie, vol. 57, no. 5, pp. 430–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. Y.-C. Chen, S.-Y. Wang, and C.-C. King, “Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism,” Journal of Virology, vol. 73, no. 4, pp. 2650–2657, 1999. View at Google Scholar · View at Scopus
  33. A. C. Shurtleff, D. W. C. Beasley, J. J. Y. Chen et al., “Genetic variation in the 3′ non-coding region of dengue viruses,” Virology, vol. 281, no. 1, pp. 75–87, 2001. View at Google Scholar
  34. E. C. Holmes and S. S. Twiddy, “The origin, emergence and evolutionary genetics of dengue virus,” Infection, Genetics and Evolution, vol. 3, no. 1, pp. 19–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. D. A. Muller and P. R. Young, “The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker,” Antiviral Research, vol. 98, no. 2, pp. 192–208, 2013. View at Publisher · View at Google Scholar
  36. WHO-Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, 2nd edition, 1997, http://www.who.int/csr/resources/publications/dengue/Denguepublication/en.
  37. G. A. Macedo, M. L. C. Gonin, S. M. Pone, O. G. Cruz, F. F. Nobre, and P. Brasil, “Sensitivity and specificity of the World Health Organization dengue classification schemes for severe dengue assessment in children in Rio de Janeiro,” PLoS ONE, vol. 9, no. 4, Article ID e96314, 2014. View at Google Scholar
  38. P. Avirutnan, N. Punyadee, S. Noisakran et al., “Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement,” Journal of Infectious Diseases, vol. 193, no. 8, pp. 1078–1088, 2006. View at Google Scholar
  39. C.-F. Lin, H.-Y. Lei, A.-L. Shiau et al., “Endothelial cell apoptosis induced by antibodies against dengue virus nonstructural protein 1 via production of nitric oxide,” The Journal of Immunology, vol. 169, no. 2, pp. 657–664, 2002. View at Google Scholar
  40. P. Vallance and S. Moncada, “Nitric oxide-from mediator to medicines,” Journal of the Royal College of Physicians of London, vol. 28, no. 3, pp. 209–219, 1994. View at Google Scholar
  41. W. C. Sessa, “The nitric oxide synthase family of proteins,” Journal of Vascular Research, vol. 31, no. 3, pp. 131–143, 1994. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Sanchez, M. Lukwiya, D. Bausch et al., “Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels,” Journal of Virology, vol. 78, no. 19, pp. 10370–10377, 2004. View at Google Scholar
  43. S. Mocellin, V. Bronte, and D. Nitti, “Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities,” Medicinal Research Reviews, vol. 27, no. 3, pp. 317–352, 2007. View at Google Scholar
  44. A. Levy, N. Valero, L. M. Espina, G. Añez, J. Arias, and J. Mosquera, “Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 104, no. 1, pp. 16–23, 2010. View at Publisher · View at Google Scholar
  45. J. D. Teo, P. A. Macary, and K. S. Tan, “Pleiotropic effects of Blastocystis spp. subtypes 4 and 7 on ligand-specific toll-like receptor signaling and NF-κB activation in a human monocyte cell line,” PLoS ONE, vol. 9, no. 2, Article ID e89036, 2014. View at Publisher · View at Google Scholar
  46. N. Modhiran, S. Kalayanarooj, and S. Ubol, “Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapse,” PLoS neglected tropical diseases, vol. 4, no. 12, article e924, 2010. View at Google Scholar